Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris E Beldhuis

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Heart Failure|July 27, 2022
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trialSafia Chatur, Muthiah Vaduganathan, Alexander Peikert, et al.
European Journal of Heart Failure|July 18, 2023
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failureIris E Beldhuis, Kevin Damman, Peter S Pang, et al.
European Journal of Heart Failure|April 10, 2026
Spironolactone, Early Acute eGFR Changes, and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT AmericasIris E Beldhuis, Brian L Claggett, Brendon L Neuen, et al.
JACC. Heart Failure|January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney DiseaseIris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
European Journal of Heart Failure|October 29, 2025
Outpatient loop diuretic use and the effect of natriuresis-guided diuretic therapy: A prespecified sub-analysis of the PUSH-AHF studyLara E E C Zonneveld, Iris E Beldhuis, Hailun Qin, et al.
JACC. Heart Failure|March 27, 2026
Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF TrialLara E E C Zonneveld, Ambarish Pandey, Iris E Beldhuis, et al.
Scientific Reports|August 18, 2024
Association of fibrotic markers with diastolic function after STEMILawien Al Ali, Wouter C Meijers, Iris E Beldhuis, et al.
Journal of Cardiac Failure|April 27, 2026
IL-6 and diuretic response in acute heart failureDaan C H Ceelen, Lukas Baumhove, Bart J van Essen, et al.
Journal of the American College of Cardiology|April 8, 2024
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart FailureSafia Chatur, Brendon L Neuen, Brian L Claggett, et al.
Circulation. Heart Failure|December 21, 2018
Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection FractionPeder L Myhre, Eileen O'Meara, Brian L Claggett, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Heart Failure|July 27, 2022
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trialSafia Chatur, Muthiah Vaduganathan, Alexander Peikert, et al.
European Journal of Heart Failure|July 18, 2023
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failureIris E Beldhuis, Kevin Damman, Peter S Pang, et al.
European Journal of Heart Failure|April 10, 2026
Spironolactone, Early Acute eGFR Changes, and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT AmericasIris E Beldhuis, Brian L Claggett, Brendon L Neuen, et al.
JACC. Heart Failure|January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney DiseaseIris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
European Journal of Heart Failure|October 29, 2025
Outpatient loop diuretic use and the effect of natriuresis-guided diuretic therapy: A prespecified sub-analysis of the PUSH-AHF studyLara E E C Zonneveld, Iris E Beldhuis, Hailun Qin, et al.
JACC. Heart Failure|March 27, 2026
Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF TrialLara E E C Zonneveld, Ambarish Pandey, Iris E Beldhuis, et al.
Scientific Reports|August 18, 2024
Association of fibrotic markers with diastolic function after STEMILawien Al Ali, Wouter C Meijers, Iris E Beldhuis, et al.
Journal of Cardiac Failure|April 27, 2026
IL-6 and diuretic response in acute heart failureDaan C H Ceelen, Lukas Baumhove, Bart J van Essen, et al.
Journal of the American College of Cardiology|April 8, 2024
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart FailureSafia Chatur, Brendon L Neuen, Brian L Claggett, et al.
Circulation. Heart Failure|December 21, 2018
Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection FractionPeder L Myhre, Eileen O'Meara, Brian L Claggett, et al.
Pageof 4